155 related articles for article (PubMed ID: 6770206)
1. [Treatment of blood diseases in a specialized department].
Beran M; Carlmark B; Ehn L; Ericsson F; Forsberg K; Hast R; Höglund S; Lantz B; Pihlstedt P; Reizenstein P; Skårberg KO; Udén AM; Osby E
Lakartidningen; 1980 Apr; 77(17):1635-9. PubMed ID: 6770206
[No Abstract] [Full Text] [Related]
2. [Plasmapheresis].
Speiser P
Wien Klin Wochenschr; 1967 Sep; 79(38):689-92. PubMed ID: 4969820
[No Abstract] [Full Text] [Related]
3. [Clinical use of plasmapheresis].
Del Favero A; Morelli A; Narducci F
Clin Ter; 1981 Jan; 96(1):93-9. PubMed ID: 6786819
[No Abstract] [Full Text] [Related]
4. Apheresis in hematologic and oncologic disease.
Cohen RJ
Hosp Pract (Off Ed); 1983 Oct; 18(10):199-205. PubMed ID: 6413369
[TBL] [Abstract][Full Text] [Related]
5. [Hematology 2010].
Dreyling M; Subklewe M; Braess J; Spiekermann K
Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1322-5. PubMed ID: 20556691
[No Abstract] [Full Text] [Related]
6. Plasmapheresis in patients with leukaemia, multiple myeloma and immune complex diseases.
Mód A; Füst G; Harsányi V; Natonek K; Poros A; Szabó J; Hollán SR
Haematologia (Budap); 1981; 14(1):49-56. PubMed ID: 6454615
[TBL] [Abstract][Full Text] [Related]
7. [Care of hematologic patients].
István L
Orv Hetil; 1973 Dec; 114(51):3061-7. PubMed ID: 4769427
[No Abstract] [Full Text] [Related]
8. Anemia, splenomegaly and hyperviscosity syndrome.
Pruzanski W; Chu R; Damji NF; Galler S; Norman CS
Can Med Assoc J; 1980 Oct; 123(8):731-7. PubMed ID: 6778602
[No Abstract] [Full Text] [Related]
9. [Blood diseases].
Bottura C
Prensa Med Argent; 1966 Sep; 53(39):2358-69. PubMed ID: 4969976
[No Abstract] [Full Text] [Related]
10. [Hemodilution and plasmapheresis in the therapy of hyperviscosity syndromes].
Di Lollo F; Fazzini G; Avanzi G
Ric Clin Lab; 1983; 13 Suppl 3():225-44. PubMed ID: 6424221
[TBL] [Abstract][Full Text] [Related]
11. [Use of plasmapheresis in surgical hematology].
Abdulkadyrov KM; Shatrov VA; Katsadze IuL
Vestn Khir Im I I Grek; 1983 Oct; 131(10):125-8. PubMed ID: 6419431
[TBL] [Abstract][Full Text] [Related]
12. [Plasmapheresis and hyperviscosity syndrome].
Corral Alonso M; Barbolla ML
Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
[No Abstract] [Full Text] [Related]
13. Hematologic disorders in the elderly.
Walsh JR
West J Med; 1981 Dec; 135(6):446-54. PubMed ID: 6801866
[TBL] [Abstract][Full Text] [Related]
14. [Plasmapheresis in the treatment of paraproteinemic hemoblastoses].
Ryzhko VV; Gorodetskiĭ VM
Ter Arkh; 1983; 55(11):70-5. PubMed ID: 6419367
[No Abstract] [Full Text] [Related]
15. [Use of plasma subsititutes solutions in patients with diseases of the blood system].
Rozanova LM; Pesterova VV; Mets VN; Gefen NG; Rogacheva SP
Probl Gematol Pereliv Krovi; 1976 Feb; 21(2):43-6. PubMed ID: 943788
[No Abstract] [Full Text] [Related]
16. [Organizational experience with the specialized treatment of blood diseases].
Chaĭka KD
Voen Med Zh; 1982 Aug; (8):47-8. PubMed ID: 7147770
[No Abstract] [Full Text] [Related]
17. Clinical and managed care issues in blood and marrow transplantation for hematologic diseases. Report of a symposium, 14 March 1996, Washington, DC.
Beatty PG
Exp Hematol; 1997 Oct; 25(11):1195-208. PubMed ID: 9328457
[No Abstract] [Full Text] [Related]
18. [Experiences of dispensary care of patients with hematologic diseases].
Runge A
Z Arztl Fortbild (Jena); 1968 Jan; 62(1):40-2. PubMed ID: 4973206
[No Abstract] [Full Text] [Related]
19. Common hematologic problems: diagnosis and treatment.
Freedman ML
Geriatrics; 1983 Apr; 38(4):119-23, 127-30, 134. PubMed ID: 6832586
[No Abstract] [Full Text] [Related]
20. [Clinical study on the effect of human lymphoblastoid interferon in B-cell malignancies].
Takeyama H; Yano K; Kataoka T; Watanabe E; Kobayashi M; Ohno R
Rinsho Ketsueki; 1984 Dec; 25(12):1921-7. PubMed ID: 6442741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
